Cell-free DNA dynamics and progression-free survival in metastatic gastroesophageal adenocarcinoma: insights from the REGIRI-PRODIGE 58 ancillary study

This cohort/real-world study was triaged for T3 - Early Cancer Detection based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

This cohort/real-world study was triaged for T3 - Early Cancer Detection based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

What the study was

Study design

Cohort/real-world study

Sample size

34

Maturity

Validated

Journal

NPJ precision oncology

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.